Hematology TimesDuvelisib NDA granted priority reviewApril 10, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology NewsExperimental voxtalisib shows mixed results in phase 2 studyMarch 22, 2018CLLAggressive LymphomasLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology NewsOutpatient CAR T infusions feasible using liso-celMarch 12, 2018Aggressive LymphomasLymphoma & Plasma Cell DisordersCellular TherapyImmunotherapyMantle Cell LymphomaFollicular Lymphoma
Hematology NewsBest options for treating relapsed/refractory PTCLMarch 8, 2018T Cell LymphomasAggressive LymphomasLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology TimesCompany withdraws application for idelalisibMarch 1, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology NewsBasiliximab/BEAM may improve post-ASCT outcomes in PTCLFebruary 21, 2018T Cell LymphomasAggressive LymphomasLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology TimesAssay identifies actionable mutations in lymphoid malignanciesFebruary 9, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesCombo is preferentially active in T-cell lymphomasFebruary 7, 2018Lymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology NewsTRANSCEND NHL trial identifies window for CAR T expansionFebruary 6, 2018Aggressive LymphomasLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology NewsBTK inhibitor zanubrutinib active in non-Hodgkin lymphomasJanuary 2, 2018Mantle Cell LymphomaIndolent LymphomaAggressive LymphomasLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology TimesUpdate reveals ongoing responses in ZUMA-1December 29, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesRisk stratification may be possible with JCAR017December 21, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
The Journal of Community and Supportive OncologyCancer care in 2017: the promise of more cures with the challenges of an unstable health care systemDecember 15, 2017Follicular Lymphoma
Hematology TimesPrimary analysis confirms interim findings of CTL019 in DLBCLDecember 15, 2017Lymphoma & Plasma Cell DisordersAggressive LymphomasFollicular Lymphoma
Hematology NewsVIDEO - New lymphoma drug approvals: Clinical use, future directionsDecember 14, 2017Mantle Cell LymphomaAggressive LymphomasLymphoma & Plasma Cell DisordersImmuno-oncologyFollicular Lymphoma
